T Rowe PR Health Science-InvPRHSX
13F holders, Q2 2026 (June 30)3holders +1
1new positions
0sold out
$90.48avg. 13F price*
At the end of Q2 2026, 3 institutions reported holding T Rowe PR Health Science-Inv (PRHSX) in their 13F filings, up 1 from Q1 2026. 1 opened new positions and 0 sold out. The largest holders were Ethos Financial Group, LLC ($216K), Westside Investment Management, Inc. ($131K) and Financial Gravity Companies, Inc. ($11K).
- Company
- T Rowe PR Health Science-Inv
- CUSIP
- 741480107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $216K |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 2,372 shares bought, net +2,372 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Ethos Financial Group, LLC | 0.01% | New | 2,372 | $216K |
| Westside Investment Management, Inc. | 0.02% | No change | 1,467 | $131K |
| Financial Gravity Companies, Inc. | 0.00% | — | 122 | $11K |
"% of holder's portfolio" is PRHSX's weight in each manager's 13F, not the share of T Rowe PR Health Science-Inv the manager owns.